Istanbul University - Cerrahpasa
Güzin famous suvari
Preeclampsia, affecting 2-8% of pregnancies globally, is a leading hypertensive disorder in pregnancy. It is clinically characterized by elevated blood pressure (≥140/90 mmHg) after the 20th gestational week, often accompanied by proteinuria and systemic complications such as thrombocytopenia, liver dysfunction, and cerebral symptoms. This condition poses significant risks for both maternal and fetal health, increasing the likelihood of organ damage, preterm birth, and long-term cardiovascular and neurodevelopmental complications. Non-pharmacological interventions, including relaxation techniques, have been explored for symptom management. Progressive muscle relaxation (PMR) has shown efficacy in reducing stress, anxiety, and blood pressure. Recently, virtual reality (VR)-based relaxation techniques have gained attention for enhancing stress relief and improving health outcomes. This study aims to compare the effects of VR-based PMR with in-person PMR on maternal and fetal outcomes in preeclamptic pregnancies.
Pre-Eclampsia
Maternal Health
Relaxation
Virtual Reality
Fetal Monitoring
Virtual Reality Based Progressive Muscle Relaxation
Face-to-Face Progressive Muscle Relaxation
NA
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 96 participants |
Masking : | SINGLE |
Masking Description : | This study employs a single-blind design, where participants will be unaware of their assigned intervention group (VR-based progressive muscle relaxation or in-person progressive muscle relaxation). However, researcher administering the interventions will be informed of group assignments. To ensure ethical compliance, separate informed consent forms have been prepared for each group, detailing the intervention. |
Primary Purpose : | SUPPORTIVE_CARE |
Official Title : | The Effect of Virtual Reality-Based and Face-to-Face Relaxation Programs on Maternal and Fetal Outcomes in Pregnant Women with Preeclampsia |
Actual Study Start Date : | 2025-07-01 |
Estimated Primary Completion Date : | 2026-07-01 |
Estimated Study Completion Date : | 2026-12-01 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | FEMALE |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
No Location Found